▶ 調査レポート

GLP-1類似体の世界市場2023:エクセナチド、リラグルチド、セマグルチド、デュラグルチド、その他

• 英文タイトル:Global GLP-1 Analogues Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global GLP-1 Analogues Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029「GLP-1類似体の世界市場2023:エクセナチド、リラグルチド、セマグルチド、デュラグルチド、その他」(市場規模、市場予測)調査レポートです。• レポートコード:MRC308GR11396
• 出版社/出版日:GlobalInfoResearch / 2023年8月
• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医薬品&ヘルスケア
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Corporate User¥783,000 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要

GlobalInfoResearchの最新の調査によると、世界のGLP-1類似体の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。

このレポートは、世界のGLP-1類似体市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– GLP-1類似体の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため

GLP-1類似体市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・エクセナチド、リラグルチド、セマグルチド、デュラグルチド、その他

用途別セグメント
・病院、診療所、その他

主要な市場プレーヤー
・Novo Nordisk、AstraZeneca、Eli Lily、GSK、Sanofi、Jiangsu Hansoh Pharmaceutical、Shanghai Benemae Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、GLP-1類似体製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なGLP-1類似体メーカーの企業概要、2019年~2022年までのGLP-1類似体の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なGLP-1類似体メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別GLP-1類似体の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までのGLP-1類似体の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域でのGLP-1類似体市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびGLP-1類似体の産業チェーンを掲載しています。
・第14、15章では、GLP-1類似体の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
– GLP-1類似体の概要
– 種類別分析(2018年vs2022年vs2029年):エクセナチド、リラグルチド、セマグルチド、デュラグルチド、その他
– 用途別分析(2018年vs2022年vs2029年):病院、診療所、その他
– 世界のGLP-1類似体市場規模・予測
– 世界のGLP-1類似体生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Novo Nordisk、AstraZeneca、Eli Lily、GSK、Sanofi、Jiangsu Hansoh Pharmaceutical、Shanghai Benemae Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:エクセナチド、リラグルチド、セマグルチド、デュラグルチド、その他
・用途別分析2018年-2029年:病院、診療所、その他
・GLP-1類似体の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・GLP-1類似体のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・GLP-1類似体のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・GLP-1類似体の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・GLP-1類似体の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

レポート目次

1 Market Overview
1.1 Product Overview and Scope of GLP-1 Analogues
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global GLP-1 Analogues Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Exenatide
1.3.3 Liraglutide
1.3.4 Semaglutide
1.3.5 Dulaglutide
1.3.6 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global GLP-1 Analogues Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global GLP-1 Analogues Market Size & Forecast
1.5.1 Global GLP-1 Analogues Consumption Value (2018 & 2022 & 2029)
1.5.2 Global GLP-1 Analogues Sales Quantity (2018-2029)
1.5.3 Global GLP-1 Analogues Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk GLP-1 Analogues Product and Services
2.1.4 Novo Nordisk GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca GLP-1 Analogues Product and Services
2.2.4 AstraZeneca GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Eli Lily
2.3.1 Eli Lily Details
2.3.2 Eli Lily Major Business
2.3.3 Eli Lily GLP-1 Analogues Product and Services
2.3.4 Eli Lily GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Eli Lily Recent Developments/Updates
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business
2.4.3 GSK GLP-1 Analogues Product and Services
2.4.4 GSK GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 GSK Recent Developments/Updates
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi GLP-1 Analogues Product and Services
2.5.4 Sanofi GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Sanofi Recent Developments/Updates
2.6 Jiangsu Hansoh Pharmaceutical
2.6.1 Jiangsu Hansoh Pharmaceutical Details
2.6.2 Jiangsu Hansoh Pharmaceutical Major Business
2.6.3 Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Product and Services
2.6.4 Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
2.7 Shanghai Benemae Pharmaceutical
2.7.1 Shanghai Benemae Pharmaceutical Details
2.7.2 Shanghai Benemae Pharmaceutical Major Business
2.7.3 Shanghai Benemae Pharmaceutical GLP-1 Analogues Product and Services
2.7.4 Shanghai Benemae Pharmaceutical GLP-1 Analogues Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Shanghai Benemae Pharmaceutical Recent Developments/Updates
3 Competitive Environment: GLP-1 Analogues by Manufacturer
3.1 Global GLP-1 Analogues Sales Quantity by Manufacturer (2018-2023)
3.2 Global GLP-1 Analogues Revenue by Manufacturer (2018-2023)
3.3 Global GLP-1 Analogues Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of GLP-1 Analogues by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 GLP-1 Analogues Manufacturer Market Share in 2022
3.4.2 Top 6 GLP-1 Analogues Manufacturer Market Share in 2022
3.5 GLP-1 Analogues Market: Overall Company Footprint Analysis
3.5.1 GLP-1 Analogues Market: Region Footprint
3.5.2 GLP-1 Analogues Market: Company Product Type Footprint
3.5.3 GLP-1 Analogues Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global GLP-1 Analogues Market Size by Region
4.1.1 Global GLP-1 Analogues Sales Quantity by Region (2018-2029)
4.1.2 Global GLP-1 Analogues Consumption Value by Region (2018-2029)
4.1.3 Global GLP-1 Analogues Average Price by Region (2018-2029)
4.2 North America GLP-1 Analogues Consumption Value (2018-2029)
4.3 Europe GLP-1 Analogues Consumption Value (2018-2029)
4.4 Asia-Pacific GLP-1 Analogues Consumption Value (2018-2029)
4.5 South America GLP-1 Analogues Consumption Value (2018-2029)
4.6 Middle East and Africa GLP-1 Analogues Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global GLP-1 Analogues Sales Quantity by Type (2018-2029)
5.2 Global GLP-1 Analogues Consumption Value by Type (2018-2029)
5.3 Global GLP-1 Analogues Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global GLP-1 Analogues Sales Quantity by Application (2018-2029)
6.2 Global GLP-1 Analogues Consumption Value by Application (2018-2029)
6.3 Global GLP-1 Analogues Average Price by Application (2018-2029)
7 North America
7.1 North America GLP-1 Analogues Sales Quantity by Type (2018-2029)
7.2 North America GLP-1 Analogues Sales Quantity by Application (2018-2029)
7.3 North America GLP-1 Analogues Market Size by Country
7.3.1 North America GLP-1 Analogues Sales Quantity by Country (2018-2029)
7.3.2 North America GLP-1 Analogues Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe GLP-1 Analogues Sales Quantity by Type (2018-2029)
8.2 Europe GLP-1 Analogues Sales Quantity by Application (2018-2029)
8.3 Europe GLP-1 Analogues Market Size by Country
8.3.1 Europe GLP-1 Analogues Sales Quantity by Country (2018-2029)
8.3.2 Europe GLP-1 Analogues Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific GLP-1 Analogues Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific GLP-1 Analogues Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific GLP-1 Analogues Market Size by Region
9.3.1 Asia-Pacific GLP-1 Analogues Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific GLP-1 Analogues Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America GLP-1 Analogues Sales Quantity by Type (2018-2029)
10.2 South America GLP-1 Analogues Sales Quantity by Application (2018-2029)
10.3 South America GLP-1 Analogues Market Size by Country
10.3.1 South America GLP-1 Analogues Sales Quantity by Country (2018-2029)
10.3.2 South America GLP-1 Analogues Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa GLP-1 Analogues Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa GLP-1 Analogues Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa GLP-1 Analogues Market Size by Country
11.3.1 Middle East & Africa GLP-1 Analogues Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa GLP-1 Analogues Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 GLP-1 Analogues Market Drivers
12.2 GLP-1 Analogues Market Restraints
12.3 GLP-1 Analogues Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of GLP-1 Analogues and Key Manufacturers
13.2 Manufacturing Costs Percentage of GLP-1 Analogues
13.3 GLP-1 Analogues Production Process
13.4 GLP-1 Analogues Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 GLP-1 Analogues Typical Distributors
14.3 GLP-1 Analogues Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global GLP-1 Analogues Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global GLP-1 Analogues Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk GLP-1 Analogues Product and Services
Table 6. Novo Nordisk GLP-1 Analogues Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca GLP-1 Analogues Product and Services
Table 11. AstraZeneca GLP-1 Analogues Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Eli Lily Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lily Major Business
Table 15. Eli Lily GLP-1 Analogues Product and Services
Table 16. Eli Lily GLP-1 Analogues Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Eli Lily Recent Developments/Updates
Table 18. GSK Basic Information, Manufacturing Base and Competitors
Table 19. GSK Major Business
Table 20. GSK GLP-1 Analogues Product and Services
Table 21. GSK GLP-1 Analogues Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. GSK Recent Developments/Updates
Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Major Business
Table 25. Sanofi GLP-1 Analogues Product and Services
Table 26. Sanofi GLP-1 Analogues Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Sanofi Recent Developments/Updates
Table 28. Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Jiangsu Hansoh Pharmaceutical Major Business
Table 30. Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Product and Services
Table 31. Jiangsu Hansoh Pharmaceutical GLP-1 Analogues Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
Table 33. Shanghai Benemae Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 34. Shanghai Benemae Pharmaceutical Major Business
Table 35. Shanghai Benemae Pharmaceutical GLP-1 Analogues Product and Services
Table 36. Shanghai Benemae Pharmaceutical GLP-1 Analogues Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Shanghai Benemae Pharmaceutical Recent Developments/Updates
Table 38. Global GLP-1 Analogues Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global GLP-1 Analogues Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global GLP-1 Analogues Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in GLP-1 Analogues, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and GLP-1 Analogues Production Site of Key Manufacturer
Table 43. GLP-1 Analogues Market: Company Product Type Footprint
Table 44. GLP-1 Analogues Market: Company Product Application Footprint
Table 45. GLP-1 Analogues New Market Entrants and Barriers to Market Entry
Table 46. GLP-1 Analogues Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global GLP-1 Analogues Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global GLP-1 Analogues Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global GLP-1 Analogues Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global GLP-1 Analogues Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global GLP-1 Analogues Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global GLP-1 Analogues Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global GLP-1 Analogues Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global GLP-1 Analogues Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global GLP-1 Analogues Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global GLP-1 Analogues Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global GLP-1 Analogues Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global GLP-1 Analogues Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global GLP-1 Analogues Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global GLP-1 Analogues Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global GLP-1 Analogues Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global GLP-1 Analogues Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global GLP-1 Analogues Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global GLP-1 Analogues Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America GLP-1 Analogues Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America GLP-1 Analogues Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America GLP-1 Analogues Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America GLP-1 Analogues Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America GLP-1 Analogues Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America GLP-1 Analogues Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America GLP-1 Analogues Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America GLP-1 Analogues Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe GLP-1 Analogues Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe GLP-1 Analogues Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe GLP-1 Analogues Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe GLP-1 Analogues Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe GLP-1 Analogues Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe GLP-1 Analogues Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe GLP-1 Analogues Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe GLP-1 Analogues Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific GLP-1 Analogues Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific GLP-1 Analogues Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific GLP-1 Analogues Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific GLP-1 Analogues Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific GLP-1 Analogues Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific GLP-1 Analogues Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific GLP-1 Analogues Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific GLP-1 Analogues Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America GLP-1 Analogues Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America GLP-1 Analogues Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America GLP-1 Analogues Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America GLP-1 Analogues Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America GLP-1 Analogues Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America GLP-1 Analogues Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America GLP-1 Analogues Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America GLP-1 Analogues Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa GLP-1 Analogues Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa GLP-1 Analogues Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa GLP-1 Analogues Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa GLP-1 Analogues Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa GLP-1 Analogues Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa GLP-1 Analogues Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa GLP-1 Analogues Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa GLP-1 Analogues Consumption Value by Region (2024-2029) & (USD Million)
Table 105. GLP-1 Analogues Raw Material
Table 106. Key Manufacturers of GLP-1 Analogues Raw Materials
Table 107. GLP-1 Analogues Typical Distributors
Table 108. GLP-1 Analogues Typical Customers
List of Figures
Figure 1. GLP-1 Analogues Picture
Figure 2. Global GLP-1 Analogues Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global GLP-1 Analogues Consumption Value Market Share by Type in 2022
Figure 4. Exenatide Examples
Figure 5. Liraglutide Examples
Figure 6. Semaglutide Examples
Figure 7. Dulaglutide Examples
Figure 8. Other Examples
Figure 9. Global GLP-1 Analogues Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global GLP-1 Analogues Consumption Value Market Share by Application in 2022
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Other Examples
Figure 14. Global GLP-1 Analogues Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global GLP-1 Analogues Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global GLP-1 Analogues Sales Quantity (2018-2029) & (K Units)
Figure 17. Global GLP-1 Analogues Average Price (2018-2029) & (US$/Unit)
Figure 18. Global GLP-1 Analogues Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global GLP-1 Analogues Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of GLP-1 Analogues by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 GLP-1 Analogues Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 GLP-1 Analogues Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global GLP-1 Analogues Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global GLP-1 Analogues Consumption Value Market Share by Region (2018-2029)
Figure 25. North America GLP-1 Analogues Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe GLP-1 Analogues Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific GLP-1 Analogues Consumption Value (2018-2029) & (USD Million)
Figure 28. South America GLP-1 Analogues Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa GLP-1 Analogues Consumption Value (2018-2029) & (USD Million)
Figure 30. Global GLP-1 Analogues Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global GLP-1 Analogues Consumption Value Market Share by Type (2018-2029)
Figure 32. Global GLP-1 Analogues Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global GLP-1 Analogues Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global GLP-1 Analogues Consumption Value Market Share by Application (2018-2029)
Figure 35. Global GLP-1 Analogues Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America GLP-1 Analogues Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America GLP-1 Analogues Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America GLP-1 Analogues Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America GLP-1 Analogues Consumption Value Market Share by Country (2018-2029)
Figure 40. United States GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe GLP-1 Analogues Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe GLP-1 Analogues Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe GLP-1 Analogues Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe GLP-1 Analogues Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific GLP-1 Analogues Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific GLP-1 Analogues Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific GLP-1 Analogues Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific GLP-1 Analogues Consumption Value Market Share by Region (2018-2029)
Figure 56. China GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America GLP-1 Analogues Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America GLP-1 Analogues Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America GLP-1 Analogues Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America GLP-1 Analogues Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa GLP-1 Analogues Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa GLP-1 Analogues Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa GLP-1 Analogues Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa GLP-1 Analogues Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa GLP-1 Analogues Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. GLP-1 Analogues Market Drivers
Figure 77. GLP-1 Analogues Market Restraints
Figure 78. GLP-1 Analogues Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of GLP-1 Analogues in 2022
Figure 81. Manufacturing Process Analysis of GLP-1 Analogues
Figure 82. GLP-1 Analogues Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source